Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| Calabrò E et al. | 2020 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | 50/60 Hz, magnetic field | - |
| Tekam CKS et al. | 2023 | intact cell/cell culture, C6 glial cells, animal, rat/Wistar | 50/60 Hz, magnetic field, signals/pulses | - |
| Lazzarini R et al. | 2023 | intact cell/cell culture, MDA-MB-231 cells (breast cancer cell line) and MDA-MB-231 (human breast cell line) | magnetic field, 50/60 Hz | - |
| Shoorche AB et al. | 2023 | intact cell/cell culture, MG-63 cells (human osteosarcoma cell line) | magnetic field, low frequency, 50/60 Hz, signals/pulses | - |
| Sendera A et al. | 2024 | intact cell/cell culture, human adipose-derived mesenchymal stem cells | magnetic field, 50/60 Hz, low frequency | - |
| Eremenko T et al. | 1997 | intact cell/cell culture, Friend erythroleukemia cell line (clone 745 A) | magnetic field, geomagnetic field, 50/60 Hz, shielding/field deprivation | 0.0025 nT–70 µT |
| Blackman CF et al. | 1993 | intact cell/cell culture, PC-12D cells (subline of the PC-12 cell line, derived from pheochromocytoma cells from the rat adrenal medulla) | magnetic field, 50/60 Hz | 0.4–40 µT |
| McFarlane EH et al. | 2000 | intact cell/cell culture, PC-12 cells (pheochromocytoma cell line from rat adrenal gland) | magnetic field, 50/60 Hz | 4.35–15.8 µT |
| Matsushima S et al. | 1993 | animal, rat/Wistar-King, whole body | magnetic field, 50/60 Hz | 5 µT |
| Nafziger J et al. | 1997 | intact cell/cell culture, human bone marrow cells | magnetic field, 50/60 Hz | 10 µT–1 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
